| dc.creator |
Dereli, Fatma Tuğçe |
|
| dc.creator |
AKKOL, ESRA |
|
| dc.creator |
Khan, Haroon |
|
| dc.creator |
Sobarzo-Sanchez, Eduardo |
|
| dc.date |
2020-01-01T00:00:00Z |
|
| dc.date.accessioned |
2023-01-09T12:04:34Z |
|
| dc.date.available |
2023-01-09T12:04:34Z |
|
| dc.identifier |
7d66001f-4229-4be2-b720-cf769b66ac0d |
|
| dc.identifier |
10.2174/1568026620666200416084440 |
|
| dc.identifier |
https://avesis.sdu.edu.tr/publication/details/7d66001f-4229-4be2-b720-cf769b66ac0d/oai |
|
| dc.identifier.uri |
http://acikerisim.sdu.edu.tr/xmlui/handle/123456789/98043 |
|
| dc.description |
Gynecologic cancers, including cervical, primary peritoneal, ovarian, uterine/endometrial, vaginal and vulvar cancers and gestational trophoblastic disease, are characterized by abnormal cell proliferation in female reproductive cells. Due to the variable pathology of these cancers and the lack of appropriate screening tests in developing countries, cancer diagnosis can be reported in advanced stages in most women and this situation adversely affects prognosis and clinical outcomes of illness. For this reason, many researchers in the field of gynecological oncology have carried out many studies. |
|
| dc.language |
eng |
|
| dc.rights |
info:eu-repo/semantics/closedAccess |
|
| dc.title |
Roles of Medicinal Plants and Constituents in Gynecological Cancer Therapy: Current Literature and Future Directions |
|
| dc.type |
info:eu-repo/semantics/article |
|